DENOSUMAB (DMAB) TREATMENT FOR 6 YEARS MAINTAINS LOW FRACTURE INCIDENCE IN WOMEN >= 75 YEARS WITH POSTMENOPAUSAL OSTEOPOROSIS (PMO)

Author(s):
Papapoulos, S.; Mcclung, M.R.; Franchimont, N.; Adachi, J.D.; Bone, H.G.; Benhamou, C.L.; Farrerons, J.; Gallagher, J.C.; Halse, J.; Lippuner, K.; Man, Z.; Minisola, S.; Torring, O.; Daizadeh, N.; Wang, A.; Wagman, R.B.; Boonen, S.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-04-30
Language
English
Is part of
hdl
1887/100239